Ibrutinib and Palbociclib in Treating Patients With Previously Treated Mantle Cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Galapagos NV
Merck Sharp & Dohme LLC
University of Washington
The Lymphoma Academic Research Organisation
Eli Lilly and Company
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Hackensack Meridian Health
Acerta Pharma BV
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Acerta Pharma BV
M.D. Anderson Cancer Center
AstraZeneca
City of Hope Medical Center
University of Michigan Rogel Cancer Center
Acerta Pharma BV
Guangzhou Lupeng Pharmaceutical Company LTD.
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fondazione Italiana Linfomi - ETS
M.D. Anderson Cancer Center
Gilead Sciences
Sana Biotechnology
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Washington
AstraZeneca
Ohio State University Comprehensive Cancer Center
Regeneron Pharmaceuticals
M.D. Anderson Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Sana Biotechnology
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
BeiGene
BeiGene
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
Weill Medical College of Cornell University
Eli Lilly and Company
City of Hope Medical Center